- Home
- TNET vs OCUL Comparison
TNET vs OCUL Comparison
Compare TNET & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNET
- OCUL
- Stock Information
- Founded
- TNET 1988
- OCUL 2006
- Country
- TNET United States
- OCUL United States
- Employees
- TNET N/A
- OCUL N/A
- Industry
- TNET Business Services
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- TNET Consumer Discretionary
- OCUL Health Care
- Exchange
- TNET Nasdaq
- OCUL Nasdaq
- Market Cap
- TNET 2.6B
- OCUL 2.3B
- IPO Year
- TNET 2014
- OCUL 2014
- Fundamental
- Price
- TNET $58.86
- OCUL $12.11
- Analyst Decision
- TNET Hold
- OCUL Strong Buy
- Analyst Count
- TNET 4
- OCUL 10
- Target Price
- TNET $77.33
- OCUL $22.33
- AVG Volume (30 Days)
- TNET 480.7K
- OCUL 2.6M
- Earning Date
- TNET 10-29-2025
- OCUL 11-04-2025
- Dividend Yield
- TNET 1.88%
- OCUL N/A
- EPS Growth
- TNET N/A
- OCUL N/A
- EPS
- TNET 2.65
- OCUL N/A
- Revenue
- TNET $4,971,000,000.00
- OCUL $55,783,000.00
- Revenue This Year
- TNET $2.49
- OCUL N/A
- Revenue Next Year
- TNET $3.17
- OCUL $17.75
- P/E Ratio
- TNET $22.08
- OCUL N/A
- Revenue Growth
- TNET N/A
- OCUL N/A
- 52 Week Low
- TNET $54.22
- OCUL $5.79
- 52 Week High
- TNET $97.02
- OCUL $13.85
- Technical
- Relative Strength Index (RSI)
- TNET 51.93
- OCUL 56.38
- Support Level
- TNET $54.22
- OCUL $11.63
- Resistance Level
- TNET $59.37
- OCUL $12.50
- Average True Range (ATR)
- TNET 1.47
- OCUL 0.56
- MACD
- TNET 0.68
- OCUL 0.10
- Stochastic Oscillator
- TNET 89.13
- OCUL 74.93
About TNET TriNet Group Inc.
Trinet Group Inc outsourced payroll and human capital management solutions for small and midsize businesses via a professional employer organization model. Under the PEO model, TriNet enters a co-employment arrangement and acts as the employer of record for administrative and regulatory purposes for clients' employees, known as worksite employees. Clients leverage the scale and expertise of TriNet to access competitive employee benefits, share employment risk liability, access compliance support, and outsource mission-critical day-to-day HR functions such as payroll and tax administration. Following the acquisition of Zenefits and Clarus R+D in 2022, TriNet derives the minority of its revenue from self-service HCM software and R&D tax credit services.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.